Iontophoresis in transdermal delivery

Enhancement in Drug Delivery

Volumn , Issue , 2006, Pages 279-302

  Mudry, Blaise ^a   Guy, Richard H ^b   Delgado Charro, M Begoña ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 54949110604     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (126)

1. Gangarosa, L.P., and J.M. Hill. 1995. Modern iontophoresis for local drug delivery. Int J Pharm 123:159.
2. Zempsky, W.T., and M.A. Ashburn. 1998. Iontophoresis: Non-invasive drug delivery. Am J Anaesthesiol 25:158.
3. Behar-Cohen, F.-F., et al. 2002. Trans-scleral coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: Influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels. Exp Eye Res 74:51.
4. Halhal, M. 2004. Iontophoresis: From the lab to the bed side. Exp Eye Res 78:751.
5. Yoshizuma, M.O., et al. 1991. Experimental trans-scleral iontophoresis of ciprofloxacin. J Ocul Opthalmol 7:163.
6. Kalia, Y.N., et al. 2004. Iontophoretic drug delivery. Adv Drug Deliv Rev 56 (5):619.
7. Leboulanger, B., R.H. Guy, and M.B. Delgado-Charro. 2004. Reverse iontophoresis for noninvasive transdermal monitoring. Physiol Meas 25 (3):R35.
8. Delgado-Charro, M.B., and R.H. Guy. 1998. Percutaneous penetration and transdermal drug delivery. Prog Dermatol 32:1.
9. Delgado-Charro, M.B., and R.H. Guy. 2001. Transdermal drug delivery. In Drug delivery and targeting for pharmacists and pharmaceuticals scientists, ed. A.M. Hillery, A.W. Lloyd, and J. Swarbrick, 207. London: Taylor & Francis.
10. Pikal, M.J., and S. Shah. 1990. Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurement for hairless mouse skin. Pharm Res 7 (3):213.
11. Burnette, R.R., and D. Marrero. 1986. Comparison between the iontophoretic and passive. Transport of thyrotropin releasing hormone across excised nude mouse skin. J Pharm Sci 75 (8):738.
12. Sekkat, N., Y.N. Kalia, and R.H. Guy. 2004. Porcine ear skin as a model for the assessment of transdermal drug delivery to premature neonates. Pharm Res 21:1290.
13. Phipps, J.B., R.V. Padmanabhan, and G.A. Lattin. 1989. Iontophoretic delivery of model inorganic and drug ions. J Pharm Sci 78 (5):365.
14. Denet, A.-R., R. Vanbever, and V. Preat. 2004. Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev 56:5.
15. Brett, C.M.A., and A.M.O. Brett. 1998. Electrochemistry: Principles, methods, and applications, 1st ed., New York: Oxford University Press, chap. 2.
16. Green, P.G. 1996. Iontophoretic delivery of peptide drugs. J Control Release 41:33.
17. Leboulanger, B., et al. 2004. Reverse iontophoresis as a non-invasive tool for lithium monitoring and pharmacokinetic profiling. Pharm Res 21 (7):1214.
18. Bellantone, N.H., et al. 1986. Enhanced percutaneous absorption via iontophoresis. I. Evaluation of an in vitro system and transport of model compounds. Int J Pharm 30 (1):63.
19. Del Terzo, S., C.R. Behl, and R.A. Nash. 1989. Iontophoretic transport of a homologous series of ionized and nonionized model compounds: Influence of hydrophobicity and mechanistic interpretation. Pharm Res 6 (1):85.
20. Padmanabhan, R.V., et al. 1990. In vitro and in vivo evaluation of transdermal iontophoretic delivery of hydromorphone. J Control Release 11 (3):123.
21. Meyer, B.R., et al. 1990. Transdermal versus subcutaneous leuprolide: A comparison of acute phamacodynamic effect. Clin Pharmacol Ther 48:340.
22. Gangarosa, L.P., et al. 1980. Increased penetration of non-electrolytes into mouse skin during iontophoretic water transport (iontohydrokinesis). J Pharmacol Exp Ther 212:377.
23. Burnette, R.R. 1987. Characterization of the permselective properties of excised human skin during iontophoresis. J Pharm Sci 76 (10):765.
24. Pikal, M.J. 1992. The role of the electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev 9:201.
25. Kim, A., et al. 1993. Convective solvent flow across the skin during iontophoresis. Pharm Res 10 (9):1315.
26. Santi, P., and R.H. Guy. 1996. Reverse iontophoresis-Parameters determining electroosmotic flow: I. pH and ionic strength. J Control Release 38:159.
27. Santi, P., and R.H. Guy. 1996. Reverse iontophoresis-Parameters determining electroosmotic flow: II. Electrode chamber formulation. J Control Release 42:29.
28. Sieg, A., R.H. Guy, and M.B. Delgado-Charro. 2003. Reverse iontophoresis for noninvasive glucose monitoring: The internal standard concept. J Pharm Sci 92 (11):2295.
29. Sieg, A., R.H. Guy, and M.B. Delgado-Charro. 2004. Non-invasive glucose monitoring by reverse iontophoresis in vivo: Application of the internal standard concept. Clin Chem 50 (8):1383.
30. Brand, R.M., and R.H. Guy. 1995. Iontophoresis of nicotine in vitro: Pulsatile drug delivery across the skin? J Control Release 33:285.
31. Sieg, A., R.H. Guy, and M.B. Delgado-Charro. 2004. Electroosmosis in transdermal iontophoresis:Implications for non-invasive and calibration-free glucose monitoring. Biophys J 87:3344.
32. Marro, D., et al. 2001. Contribution of electromigration and electroosmosis to iontophoretic drug delivery. Pharm Res 18 (12):1701.
33. Hirvonen, J., and R.H. Guy. 1997. Iontophoretic delivery across the skin: Electroosmosis and its modulation by drug substances. Pharm Res 14 (9):1258.
34. Lau, D.T.W., et al. 1994. Effect of current magnitude and drug concentration on iontophoretic delivery of octreotide acetate (Sandostatin t) in the rabbit. Pharm Res 11:1742.
35. Meyer, B.R., et al. 1988. Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers. Clin Pharmacol Ther 44:607.
36. Cullander, C. 1992. What are the pathways of iontophoretic current flow through mammalian skin? Adv Drug Deliv Rev 9:119.
37. Burnette, R.R. 1989. Iontophoresis. In Transdermal drug delivery, eds. J. Hadrgraft and R.H. Guy. New York and Basel: Marcel Dekker, chap. 11.
38. Cullander, C., and R.H. Guy. 1991. Sites of iontophoretic current flow into the skin: Identification and characterization with the vibrating probe electrode. J Invest Dermatol 97:55.
39. Gibson, L.E., and R.E. Cooke. 1959. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics (Evanston) 23:545.
40. Sato, K., et al. 1993. Generation and transit pathway of H+ is critical for inhibition of palmar sweating by iontophoresis in water. J Appl Physiol 75:2258.
41. Turner, N.G., and R.H. Guy. 1998. Visualization and quantitation of iontophoretic effect pathways using confocal microscopy. J Invest Dermatol Symp Proc 3:136.
42. Turner, N.G., and R.H. Guy. 1997. Iontophoretic transport pathways: Dependence on penetrant physicochemical pathways. J Pharm Sci 86 (12):1385.
43. Bath, D.B., et al. 2000. Scanning electrochemical microscopy of iontophoretic transport in hairless mouse skin. Analysis of the relative contribution of diffusion, migration, and electroosmosis to transport in hair follicles. J Pharm Sci 89:1537.
44. Scott, E.R., J.B. Phipps, and H.S. White. 1995. Direct imaging of molecular transport through skin. J Invest Dermatol 104:142.
45. Bath, D.B., H.S. White, and E.R. Scott. 2000. Visualization and analysis of electroosmotic flow in hairless mouse skin. Pharm Res 17 (4):471.
46. Scott, E.R., A.I. Laplaza, H.S. White, and J.B. Phipps. 1993. Transport of ionic species in skin:Contribution of pores to the overall skin conductance. Pharm Res 10:1699.
47. Uitto, O.D., and H.S. White. 2003. Electroosmotic pore transport in human skin. Pharm Res 20:646.
48. Pechtold, L.A.R.M., et al. 2001. X-ray microanalysis of cryopreserved human skin to study the effect of iontophoresis on percutaneous ion transport. Pharm Res 18:1012.
49. Monteiro-Riviere, N.A., A.O. Inman, and J.E. Riviere. 1994. Identification of the pathway of iontophoretic drug delivery: Light and ultrastructural studies using mercuric chloride in pigs. Pharm Res 11:251.
50. Finkelstein, A., and A. Mauro. 1977. Physical principles and formalisms of electrical excitability. In Handbook of Physiology, sec. 1, The nervous system, vol. I, Cellular biology of neurones, Part 1, ed. S.R. Geiger. Bethesda, MA: American Physiological Society, chap. 6.
51. Laksminarayanaiah, N. 1969. Transport phenomena in membranes. London: Academic Press.
52. Oh, S.Y., L. Leung, D. Bommannan, R.H. Guy, and R.O. Potts. Effect of current, ionic strength and temperature on the electrical properties of skin. J Control Release 27:115.
53. Sims, S.M., W.I. Higuchi, and V. Srinivasan. 1992. Skin alteration and convective solvent flow effects during iontophoresis II. Monovalent anion and cation transport across human skin. Pharm Res 9:1402.
54. Li, S.K., et al. 2003. In vitro and in vivo comparisons of constant resistance AC iontophoresis and DC iontophoresis. J Control Release 91:327.
55. Keister, J.C., and G.B. Kasting. 1986. Ionic mass transport through a homogenous membrane in the presence of a uniform electric field. J Membr Sci 29:15.
56. Kasting, G.B. 1992. Theoretical models for iontophoretic delivery. Adv Drug Deliv Rev 9:177.
57. Kasting G.B., and J.C. Keistyer. 1989. Application of electrodiffusion theory for a homogeneous membrane to iontophoretic transport through skin. J Control Release 8:195.
58. Srinivasan, V., and W.I. Higuchi. 1990. A model for iontophoresis incorporating the effect of convective solvent flow. Int J Pharm 60:133.
59. Phipps, J.B., and R. Gyory. 1992. Transdermal ion migration. Adv Drug Deliv Rev 9:137.
60. Lai, P.M., and M.S. Roberts. 1999. An analysis of solute structure-human epidermal transport relationships in epidermal iontophoresis using the ionic mobility: Pore model. J Control Release 58:323.
61. Roberts, M.S., P.M. Lai, and Y.G. Anissimov. 1998. Epidermal iontophoresis: I. Development of the ionic mobility-pore model. Pharm Res 15 (10):1569.
62. Lai, M.P., and M.S. Roberts. 1998. Epidermal iontophoresis: II. Application of the ionic mobility- pore model to the transport of local anaesthetics. Pharm Res 15 (10):1579.
63. Masada, T., et al. 1989. Examination of iontophoretic transport of ionic drugs across skin:Baseline studies with the four-electrode system. Int J Pharm 49:57.
64. Srinivasan, V., et al. 1989. Transdermal iontophoretic drug delivery: Mechanistic analysis and application to polypeptide delivery. J Pharm Sci 78:370.
65. Srinivasan, V., W.I. Higuchi, and M.H. Su. 1989. Baseline studies with four electrode system: The effect of skin permeability increase and water transport on the flux of a model uncharged solute during iontophoresis. J Control Release 10:157.
66. Luzardo-Alvarez, A., M.B. Delgado-Charro, J. Blanco-Méndez. 2001. Iontophoretic delivery of ropinirole hydrochloride: Effect of current density and vehicle formulation. Pharm Res 18 (12):1714.
67. Luzardo-Alvarez, A., M.B. Delgado-Charro, and J. Blanco-Méndez. 2003. In vivo iontophoretic administration of ropinirole hydrochloride. J Pharm Sci 92:2450.
68. Sims, S.M., W.I. Higuchi, and V. Srinivasan. 1991. Skin alteration and convective solvent flow effects during iontophoresis: I. Neutral solute transport across human skin. Int J Pharm 69:109.
69. Li, S.K., A.-H. Ghanem, K.D. Peck, and W.I. Higuchi. 1997. Characterization of the transport pathways induced during low to moderate voltage iontophoresis in human epidermal membrane. J Pharm Sci 87:40.
70. Peck, K.D., et al. 1996. Quantitative description of the effect of molecular size upon electroosmotic flux enhancement during iontophoresis for a synthetic membrane and human epidermal membrane. J Pharm Sci 85 (7):781.
71. Peck, K.D., A.-H. Ghanem, and W.I. Higuchi. 1994. Hindered diffusion of polar molecules through and effective pore radii estimates of intact and ethanol treated human epidermal membrane. Pharm Res 11 (9):1306.
72. Peck, K.D., J. Hsu, S.K. Li, A.H. Ghanem, and W. Higuchi. 1998. Flux enhancement effects of ionic surfactants upon passive and electroosmotic transdermal transport. J Pharm Sci 87:1161.
73. Li, S.K., A.H. Ghanem, K.D. Peck, and W.I. Higuchi. 1997. Iontophoretic transport across a synthetic membrane and human epidermal membrane: A study of the effects of the permeant charge. J Pharm Sci 86:681.
74. Pikal, M.J. 1990. Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis. Pharm Res 7 (2):118.
75. Pikal, M.J., and S. Shah. 1990. Transport mechanisms in iontophoresis. III. An experimental study of the contribution of electroosmotic flow and permeability change in transport of low and high molecular weight solutes. Pharm Res 7 (3):222.
76. Marro, D., R.H. Guy, and M.B. Delgado-Charro. 2001. Characterization of the iontophoretic permselectivity properties of human skin and pig skin. J Control Release 70:213.
77. Luzardo-Alvarez, A., et al. 1998. Iontophoretic permselectivity of mammalian skin: Characterization of hairless mouse and porcine membrane models. Pharm Res 15 (7):984.
78. Marro, D., Y.N. Kalia, M.B. Delgado-Charro, and R.H. Guy. 2001. Optimizing iontophoretic drug delivery: Identification and distribution of the charge-carrying species. Pharm Res 18:1709.
79. DeNuzzio, J.D., and B. Berner. 1990. Electrochemical and iontophoretic studies of human skin. J Control Release 11:105.
80. Phipps, J.B., R.V. Padmanabhan, and G.A. Lattin. 1988. Transport of ionic species through skin. Solid State Ionics 28-30:1778.
81. Leboulanger, B., J.M. Aubry, G. Gondolfi, R.H. Guy, and M.B. Delgado-Charro. 2004. Noninvasive lithium monitoring by reverse iontophoresis in vivo. Clin Chem 50:2091.
82. Turner, N.G., et al. 1997. Iontophoresis of poly- L-lysines: The role of molecular weight? Pharm Res 14:1322.
83. Guy, R.H., M.B. Delgado-Charro, and Y.N. Kalia. 2001. Iontophoretic transport across the skin. Skin Pharmacol Appl Skin Physiol 14 (Suppl. 1):35.
84. Green, P.G., et al. 1991. Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm Res 8 (9):1121.
85. Roberts, M.S., et al. 1997. Solute structure as a determinant of iontophoretic transport. In Mechanisms of transdermal drug delivery, eds. R.H.G. Potts and R.H. Guy. New York: Marcel Dekker, chap. 9.
86. Ruddy, S.B., and B.W. Hadzija. 1992. Iontophoretic permeability of polyethylene glycols through hairless rat skin: Application of hydrodynamic theory for hindered transport through liquid-filled pores. Drug Des Discov 8:207.
87. Yoshida, N.H., and M.S. Roberts. 1993. Solute molecular size and transdermal iontophoresis across excised human skin. J Control Release 25:177.
88. Tashiro, Y., et al. 2001. Effect of lipophilicity on in vivo iontophoretic delivery-I. NSAIDs. Biol Pharm Bull 24 (3):278.
89. Tashiro, Y., et al. 2001. Effect of lipophilicity on in vivo iontophoretic delivery-II. b-Blockers. Biol Pharm Bull 24 (6):671.
90. VanOrman Huff, B., G.G. Liversidge, and G.L. McIntire. 1995. The electrophoretic mobility of tripeptides as a function of pH and ionic strength: Comparison with iontophoretic flux data. Pharm Res 12:751.
91. Yoshida, N.H., and M.S. Roberts. 1995. Prediction of cathodal iontophoretic transport of various anions across excised skin from different vehicles using conductivity measurements. J Pharm Pharmacol 47:883.
92. van der Geest, R., et al. 1996. Iontophoresis of bases, nucleosides and nucleotides. Pharm Res 13:553.
93. Kasting, G.B., and L.A. Bowman. 1990. DC electrical properties of frozen, excised human skin. Pharm Res 7 (2):134.
94. Green, P.G., et al. 1992. Transdermal iontophoresis of amino acids and peptides in vitro. J Control Release 21:187.
95. Delgado-Charro, M.B., and R.H. Guy. 1994. Characterization of convective solvent flow during iontophoresis. Pharm Res 11 (7):929.
96. Delgado-Charro, M.B., and R.H. Guy. 1998. Iontophoresis of peptides. In Electronically controlled drug Delivery, eds. B. Berner and S.M. Dinh, 129. London: CRC Press, chap. 7.
97. Nugroho, A.K., et al. 2004. Transdermal iontophoresis of rotigotine: Influence of concentration, temperature and current density in human skin in vitro. J Control Release 96:159.
98. Thysman S., and V. Préat. 1993. In vivo iontophoresis of fentanyl and sufentanil in rats: Pharmacokinetics and acute antinociceptive effects. Anesth Analges 77 (1):61.
99. Santi, P., et al. 1997. Transdermal iontophoresis of salmon calcitonin can reproduce the hypocalcemic effect of intravenous administration. Farmaco 52 (6):445.
100. Suzuki, Y., et al. 2001. Iontophoretic pulsatile transdermal delivery of human parathyroid hormone (1-34). J Pharm Pharmacol 53:1227.
101. Suzuki, Y., et al. 2002. Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH (1-34). J Pharm Sci 91:350.
102. Nakamura, K., et al. 2003. Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats. Int J Pharm 218:93.
103. Hirvonen, J., F. Hueber, and R.H. Guy. 1995. Current profile regulates iontophoretic delivery of amino acids across the skin. J Control Release 37:239.
104. Lopez-Castellano, A., R.H. Guy, and M.B. Delgado-Charro. 1999. Effect of area on the iontophoretic transport of phenylalanine and propranolol across the skin. In Proceedings of the international symposium on controlled release of bioactive materials, 26, 405.
105. Ledger, P.W. 1992. Skin biological issues in electrically enhanced transdermal delivery. Adv Drug Deliv Rev 9:289.
106. Scott, E.R., et al. 2000. Electrotransport systems for transdermal delivery: A practical implementation of iontophoresis. In Handbook of pharmaceutical controlled release technology, ed. D.L. Wise. New York: Marcel Dekker, chap. 31.
107. Lopez, R.F.V., et al. 2001. Iontophoretic delivery of 5-aminolevulinic acid (ALA): Effect of pH. Pharm Res 18 (3):311.
108. Glikfeld, P., R.S. Hinz, and R.H. Guy. 1989. Noninvasive sampling of biological fluids by iontophoresis. Pharm Res 6:988.
109. Tamada, J.A., et al. 1999. Noninvasive glucosa monitoring. Comprehensive clinical results. JAMA 282:1839.
110. Delgado-Charro, M.B., and R.H. Guy. 2003. Transdermal reverse iontophoresis of valproate:A non-invasive tool for therapeutic drug monitoring. Pharm Res 20:1508.
111. Merino, V., et al. 1999. Noninvasive sampling of phenylalanine by reverse iontophoresis. J Control Release 61:65.
112. Leboulanger, B., R.H. Guy, and M.B. Delgado-Charro. 2004. Non-invasive monitoring of phenytoin by reverse iontophoresis. Euro J Pharm Sci 22 (5):427.
113. Pitzer, K.R., et al. 2001. Detection of hypoglycaemia with the GlucoWatch Biographer. Diabet Care 24:881.
114. Thysman, S., C. Hanchard, and V. Préat. 1994. Human calcitonin delivery in rats by iontophoresis. J Pharm Pharmacol 46:725.
115. Mudry, B., R.H. Guy, and M.B. Delgado-Charro. 2005. Rational optimization of iontophoretic transport across the skin. In 32th Annual meeting & exposition of the controlled release of bioactive materials. Miami, USA.
116. Clemessy, M., et al. 1995. Mechanisms involved in iontophoretic transport of angiotensin. Pharm Res 12:998.
117. Thysman, S., V. Preat, and M. Roland. 1992. Factors affecting iontophoretic mobility of metoprolol. J Pharm Sci 81:7.
118. Lopez, R.F.V., et al. 2003. Optimization of aminolevulinic acid delivery by iontophoresis. J Control Release 88 (1):65.
119. Craane-van Hinsberg, W.H.M., et al. 1994. Iontophoresis of a model peptide across human skin in vitro: Effects of iontophoresis protocol, pH and ionic strength on peptide flux and skin impedance. Pharm Res 11:1296.
120. Brand, R.M., and P.L. Iversen. 1996. Iontophoretic delivery of a telomeric oligonucleotide. Pharm Res 13:851.
121. Merino, V., et al. 1999. Electrorepulsion versus electroosmosis: Effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm Res 16 (5):758.
122. Sage, B.H., and R.A. Hoke. 1996. US Patent 5,494,679, February 27.
123. Rojanasakul, Y., and J.R. Robinson. 1989. Transport mechanism of the cornea: Characterization of barrier permselectivity. Int J Pharm 55:237.
124. Gandhi R.B., and J.R. Robinson. 1991. Permselective characteristics of rabbit buccal mucosa. Pharm Res 8:1199.
125. Nicoli, S., et al. 2003. Characterization of the permselective properties of rabbit skin during transdermal iontophoresis. J Pharm Sci 92 (7):1482.
126. Laksminarayanaiah, N.N. 1969. Properties of monolayers and bilayers. In Transport phenomena in membranes, 444. London: Academic Press, chap. 9.